Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, and Systemic Lupus Erythematosus Research.
The new histological criteria for the diagnosis of autoimmune hepatitis.
Analysis of Hyperexpanded T Cell Clones in <scp>SARS</scp> ‐ <scp>CoV</scp> ‐2 Vaccine‐Associated Liver Injury by Spatial Proteomics and Transcriptomics
Autoimmune-Like Hepatitis Related to SARS-CoV-2 Vaccination: Towards a Clearer Definition.
Analysis of Hyperexpanded T Cell Clones in SARS-CoV-2 Vaccine-Associated Liver Injury by Spatial Proteomics and Transcriptomics.
A Case of Difficult-To-Treat Autoimmune Hepatitis Successfully Managed by Tofacitinib.
General Characteristics of patients with Primary Biliary Cholangitis from Türkiye and Denmark.
Evaluation of Histological Criteria and Immunoserological Testing of Simplified Criteria for the Diagnosis of Autoimmune Hepatitis.
Efficacy and safety of infliximab in patients with autoimmune hepatitis
Alopecia in Patients with Autoimmune Hepatitis Treated by Tacrolimus Therapy.
Non-operative management of iatrogenic esophageal perforation in a 6-year-old child.
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.
Coronavirus disease 2019 (COVID-19) in autoimmune hepatitis.
Editorial: acute severe autoimmune hepatitis-a diagnostic and therapeutic dilemma.
Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome.
Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis
Autoimmune hepatitis triggered by COVID‐19: A report of two cases
Autoimmune hepatitis triggered by COVID-19: A report of two cases.
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation.
Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months
Editorial: the role of vitamin D in autoimmune hepatitis.
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis
Low Serum Vitamin D Levels Are Associated with Severe Histological Features and Poor Response to Therapy in Patients with Autoimmune Hepatitis
Factors Associated With Response to Therapy and Outcome of Patients With Primary Biliary Cirrhosis With Features of Autoimmune Hepatitis